Atheln, Inc. vs MMS Holdings

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/athelnbiomed/mmsholdings

Category	Atheln, Inc.	MMS Holdings
Listed site	cro	cro
Summary	Atheln provides integrated consulting and strategic development services across product development, CMC, nonclinical, clinical, regulatory affairs, and commercialization for pharma, biotech, and medtech clients.	Data-focused CRO providing full-spectrum biometrics, regulatory submissions, safety & risk management, and therapeutic expertise across oncology, CNS, rare diseases, and psychedelics. Named Best Specialist CRO at the Scrip Awards with zero refusals to file on 50+ marketing applications in five years.
Services	Analytical Method Development & Validation Regulatory Affairs US FDA Regulatory Strategy EU EMA Regulatory Strategy Japan PMDA Regulatory Strategy Clinical Operations Medical Writing Translational Research	Biostatistics & Statistical Programming Data Management & eClinical Clinical Operations Phase I Clinical Trials Phase II Clinical Trials Phase III Clinical Trials Phase IV / Post-Marketing Medical Writing Pharmacovigilance & Drug Safety Regulatory Affairs US FDA Regulatory Strategy EU EMA Regulatory Strategy Japan PMDA Regulatory Strategy China NMPA Regulatory Strategy
Modalities	Small Molecule Biologics (Other) Oligonucleotide Radiopharmaceutical Peptide	Small Molecule Biologics (Monoclonal Antibodies) Biologics (Other) Vaccine Radiopharmaceutical
Indications	Ophthalmology	Oncology Neurology Psychiatry Infectious Disease Rare Disease
Locations	Data not yet provided.	Global headquarters
Certifications	Data not yet provided.	Data not yet provided.
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.